Skip to content

Drug interactions

Aprepitant + Guanfacine

Severity: Moderate

Aprepitant and Guanfacine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Aprepitant may increase guanfacine concentrations by inhibiting CYP3A4. This may cause hypotension, bradycardia and sedation.

What this interaction means in plain words

Aprepitant and Guanfacine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Aprepitant belongs to Gastrointestinal Tract; Guanfacine belongs to Cardiovascular.

Evidence level: Moderate

Why it happens

Inhibition of CYP3A4-mediated guanfacine metabolism by aprepitant.

What to do

Consider halving the extended-release guanfacine dose during coadministration. Monitor blood pressure, heart rate and sedation.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Aprepitant and Guanfacine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Aprepitant with Guanfacine?

MediHelp rates the interaction as moderate. Aprepitant and Guanfacine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Aprepitant may increase guanfacine concentrations by inhibiting CYP3A4. This may cause hypotension, bradycardia and sedation.

How serious is the interaction between Aprepitant and Guanfacine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Consider halving the extended-release guanfacine dose during coadministration. Monitor blood pressure, heart rate and sedation.

What other medicines interact with Aprepitant?

MediHelp also lists interactions of Aprepitant with, for example, Lomitapide, Pimozide, Avapritinib. The full list is on the Aprepitant page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in